Beyond Bad Luck: A Medical Guide to Recurrent Pregnancy Loss (RPL)
Subtitle: Understanding the evidence behind testing, hidden causes, and personalized treatment at Medical Art Center.
For couples trying to conceive, a single miscarriage is often devastating. When it happens a second or third time, the emotional weight is compounded by a frightening question: Is something wrong?
At Medical Art Center, we understand that Recurrent Pregnancy Loss (RPL) is not just a statistical hurdle—it is a medical mystery that deserves a thorough, evidence-based investigation. The good news? In up to 70% of cases, a cause can now be identified, and with precision medicine, the chance of a successful live birth can rise significantly.
Here is what you need to know about modern RPL testing, the overlooked causes, and why “try again” is no longer the only advice we give.
Defining RPL: When to Seek Help
Historically, RPL was defined as three consecutive losses. However, current evidence (including ASRM and ESHRE guidelines) suggests that investigation should begin after two clinical miscarriages (confirmed by ultrasound or histology).
Why? The risk of a third miscarriage after two losses is nearly 30%—similar to the risk after three. Waiting only prolongs anxiety and delays treatable diagnoses.
The Standard Workup: What Evidence-Based Testing Looks Like
Not every miscarriage requires a full RPL panel, but after two losses, a systematic approach is critical. At Medical Art Center, our RPL panel is guided by Level A evidence and includes four core domains:
1. Genetic Testing (The Embryo & The Parents)
- Parental Karyotype: 3–5% of RPL couples have a balanced chromosomal translocation (rearranged genes with no health issues for the parent, but unbalanced embryos for the baby). Finding this changes treatment dramatically (e.g., PGT-SR).
- Products of Conception (POC) Testing: If you have a third miscarriage, testing the tissue is the gold standard. 50-60% of sporadic losses are aneuploid (wrong number of chromosomes). If POC shows a normal embryo, you look harder at maternal factors.
2. Anatomic Causes (The Uterine Environment)
- 3D Sonohysterography or Hysteroscopy: We look for septate uteri (the most treatable cause), fibroids (submucosal), polyps, or adhesions (Asherman’s). Evidence: Resecting a uterine septum reduces miscarriage rates from ~80% to <15%.
3. Antiphospholipid Syndrome (APS) – The Only “Proven” Cause
- Testing: Lupus anticoagulant, anticardiolipin (IgG/IgM), and anti-β2 glycoprotein I. These must be repeated after 12 weeks to confirm persistence.
- Why it matters: Untreated APS carries a 90% fetal loss rate. Treatment with low-dose aspirin + low-molecular-weight heparin improves live birth rates to 70-80%.
4. Thyroid & Metabolic Health
- TSH: Ideal level for RPL patients is <2.5 mIU/L, not just “normal” lab range. Overt hypothyroidism is a clear risk.
- Prolactin & HbA1c: Hyperprolactinemia and poorly controlled diabetes (HbA1c >6.5%) are modifiable risks.
Beyond the Basics: Emerging Evidence-Based Causes
Many clinics stop at the four categories above. At Medical Art Center, we dig deeper when initial tests are normal.
- Endometritis (Chronic – CE): This is not the same as an acute infection. Chronic endometritis (plasma cells in the endometrium) is found in 30-40% of RPL patients. Diagnosis: Hysteroscopy with endometrial biopsy (CD138 staining). Treatment: 10-14 days of doxycycline improves live birth rates 3-fold.
- Thrombophilias (Hereditary): Factor V Leiden, Prothrombin gene mutation, MTHFR (controversial – we focus on homocysteine levels, not just MTHFR genotype). Evidence suggests hereditary thrombophilias have a weak association with early RPL but a stronger link with second-trimester loss.
- Karyomapping & PGT-A: For couples with normal karyotypes but recurrent aneuploidy, PGT-A on blastocysts reduces miscarriage rates bthat hereditary thrombophilias are associated with early RPL but exhibit a stronger associationy selecting euploid embryos.
What Does NOT Have Strong Evidence (And We Won’t Push)
Beware of “immune testing panels” that are not validated (NK cell activity, cytokine ratios, HLA sharing). These are considered experimental by ASRM. Likewise, empirical “blood thinners for everyone” without a diagnosis increases bleeding risk without benefit.
The Medical Art Center Protocol: A Step-by-Step Approach
- Comprehensive History & Couples Consultation: We review age, number of losses, gestational ages (first vs. second trimester matters), and prior testing.
- Week 1-2 (Testing): Blood draw (parental karyotype, APS, thyroid, thrombophilia panel), 3D ultrasound of the uterus, and optional semen DNA fragmentation for the male partner.
- Week 3 (Diagnosis Conference): Our RPL team (reproductive endocrinologist, embryologist, and sonographer) maps your specific profile.
- Personalized Treatment:
- Structural: Operative hysteroscopy.
- Genetic: PGT-SR or PGT-A with next IVF cycle.
- APS/Thrombophilia: Aspirin + heparin protocol starting with a positive pregnancy test.
- Endometritis: Antibiotics followed by a confirmatory biopsy.
- Unexplained RPL (30% of cases): Low-dose aspirin + progesterone (vaginal 400mg BID) starting 3 days post-ovulation, plus supportive monitoring.
Hope is Not a Strategy – Data Is
At Medical Art Center, we do not tell patients “It was just bad luck” until we have done the work to prove it. And even in unexplained RPL, we offer intensive early pregnancy surveillance (serial hCG, weekly ultrasounds from week 5-12, and reassurance).
If you have experienced two or more miscarriages, you do not need to “wait and see.” You need a map. Contact Medical Art Center today to schedule your RPL consultation—because every pregnancy deserves a plan.
Disclaimer: This blog is for educational purposes and does not replace individual medical advice. Outcomes vary based on age, diagnosis, and adherence to protocol.
Call to Action: Ready for answers? Book your Recurrent Pregnancy Loss workup at Medical Art Center – where evidence meets empathy.
